Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Key Fed inflation gauge accelerated again in August as high prices persist

Por: New York Post Business September 30, 2023

thumbnail

An inflation measure closely watched by the Federal Reserve ticked higher in August as steep prices continue to .  The personal consumption expenditures index showed that consumer prices rose 0.4% from the previous month, according to the Labor Department. On an annual basis, prices climbed 3.5% – up from 3.3% recorded the previous month, underscoring the challenge of .  The figures were both in line with estimates from Refintiv... + full article



Similar News

Fed’s preferred inflation gauge eases in June while Americans continue to spend

New York Post USA Business July 28, 2023

thumbnailSigns that inflation pressures in the United States are steadily easing emerged Friday in reports that consumer prices rose in June at their slowest pace in more than two years and that wage growth cooled last quarter. Together, the figures provided the latest signs that the... + más

What we know about the new COVID-19 variant XBB | The Boston Globe

Preferred Stocks Offer a Better Way to Bet on Banks | MarketWatch


What we know about the new COVID-19 variant XBB

The Boston Globe USA Nation December 29, 2022

thumbnailA new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más

Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC


Speedier drug approvals hit slowdown as FDA faces scrutiny

ABC News USA Business December 07, 2022

thumbnailWASHINGTON -- Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News

Speedier drug approvals hit slowdown as FDA faces scrutiny | WPLG Local 10


Speedier drug approvals hit slowdown as FDA faces scrutiny

ABC News USA Health December 07, 2022

thumbnailWASHINGTON -- Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News

Speedier drug approvals hit slowdown as FDA faces scrutiny | WPLG Local 10


Speedier drug approvals hit slowdown as FDA faces scrutiny

WPLG Local 10 USA Health December 07, 2022

thumbnailWASHINGTON – Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News


Speedier drug approvals hit slowdown as FDA faces scrutiny

Associated Press USA Politics December 07, 2022

WASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration’s controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the... + más

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News

Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News


Fed's preferred inflation gauge accelerated more than expected in August

Fox Business USA Business September 30, 2022

thumbnailAegon Asset Management chief macro strategist Frank Rybinski argues until there is a 'dovish Fed pivot' market volatility will persist on 'The Claman Countdown.' The Federal Reserve's accelerated again in August, keeping prices elevated near a... + más

Fed’s Preferred Inflation Measure Comes In Hot | Forbes

Fed Governors Shed No New Light On 4.6% Peak Funds Rate | Forbes



About iurex | Privacy Policy | Disclaimer |